Obesity and weight management for prevention and treatment of type 2 diabetes
Jiang C, Cifu AS, Sam S
JAMA. Published online, 11 July 2022
Leggi
AMD DIGITAL NETWORK – SCIENTIFIC TALK 2022-23
Carissimi Soci, come preannunciato in fase di avvio mandato, l’impegno di AMD per lo sviluppo di nuove proposte formative digital è confermato! Stiamo premendo l’acceleratore sull’AMD Digital Network con l’avvio dell’iniziativa AMD scientific talk. Una serie di webinar, della durata di circa novanta minuti, per integrare e arricchire l’offerta formativa societaria…
Leggi
Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes
Deng X, Zhang C, Wang P, et al.
J Clin Endocrinol Metab. 2022;107(7):1888-1896.
Leggi
Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes
Innes CWD, Henshall DE, Wilson B, et al.
Diabet Med. 2022;e14902.
Leggi
Loss of the incretin effect in type 2 diabetes: a systematic review and meta-analysis
Grespan E, Guolo A, Muscelli E, et al.
J Clin Endocrinol Metab. 2022;107(7):2092-2100.
Leggi
Non-inferiority and clinical superiority of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: systematic analysis of cardiorenal outcome trials in type 2 diabetes
Zaccardi F, Kloecker DE, Khunti K, Davies MJ
Diabetes Obes Metab. 2022;24(8):1598-1606.
Leggi
Prolonged use of proton pump inhibitors and risk of type 2 diabetes: results from a large population-based nested case-control study
Ciardullo S, Rea F, Savaré L, et al.
J Clin Endocrinol Metab. 2022;107(7):e2671-e2679.
Leggi
Association between SGLT2 inhibitors vs DPP4 inhibitors and renal outcomes among patients with type 2 diabetes
Au PCM, Tan KCB, Cheung BMY, et al.
J Clin Endocrinol Metab. 2022;107(7):e2962-e2970.
Leggi
Precision prognostics for the development of complications in diabetes
Schiborn C, Schulze MB
Diabetologia. Pub. online 21 Jun 2022.
Leggi